Shaker Investments’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,571
| Closed | -$452K | – | 117 |
|
|
2025
Q1 | $452K | Sell |
5,571
-4,075
| -42% | -$330K | 0.22% | 75 |
|
|
2024
Q4 | $869K | Buy |
9,646
+71
| +0.7% | +$6.39K | 0.36% | 61 |
|
|
2024
Q3 | $946K | Buy |
9,575
+3,720
| +64% | +$368K | 0.39% | 66 |
|
|
2024
Q2 | $543K | Buy |
+5,855
| New | +$543K | 0.24% | 80 |
|
|
2023
Q4 | – | Sell |
-15,724
| Closed | -$1.15M | – | 92 |
|
|
2023
Q3 | $1.15M | Sell |
15,724
-28
| -0.2% | -$2.05K | 0.63% | 53 |
|
|
2023
Q2 | $1.31M | Buy |
15,752
+205
| +1% | +$17.1K | 0.67% | 51 |
|
|
2023
Q1 | $1.18M | Buy |
15,547
+7,402
| +91% | +$564K | 0.66% | 49 |
|
|
2022
Q4 | $676K | Buy |
8,145
+2,710
| +50% | +$225K | 0.42% | 60 |
|
|
2022
Q3 | $431K | Buy |
+5,435
| New | +$431K | 0.29% | 69 |
|
|
2022
Q2 | – | Sell |
-3,031
| Closed | -$272K | – | 98 |
|
|
2022
Q1 | $272K | Sell |
3,031
-2,986
| -50% | -$268K | 0.14% | 87 |
|
|
2021
Q4 | $674K | Buy |
6,017
+27
| +0.5% | +$3.02K | 0.29% | 73 |
|
|
2021
Q3 | $753K | Buy |
5,990
+23
| +0.4% | +$2.89K | 0.33% | 70 |
|
|
2021
Q2 | $808K | Sell |
5,967
-2,123
| -26% | -$287K | 0.37% | 65 |
|
|
2021
Q1 | $1.1M | Sell |
8,090
-2,475
| -23% | -$336K | 0.53% | 56 |
|
|
2020
Q4 | $1.49M | Buy |
+10,565
| New | +$1.49M | 0.75% | 40 |
|